The impact of chronic moderate and profound hyponatremia on neurocognitive performance, motor skills and mood stability has not been investigated…
Meds news
Recent Medications Approved for Preventing Migraine Headaches
Migraine is the third most prevalent disease in the world and affects approximately 39 million individuals in the United States…
New Drugs Approved in 2019
In 2019, the US Food and Drug Administration (FDA) approved 48 novel drugs. Thirty of the 48 (62.5%) novel drug…
Chemical Industry Executive Nominated to Lead Consumer Watchdog Agency
Nancy B. Beck, who once directed science policy at the American Chemistry Council, was nominated to lead the Consumer Product…
Chemical Industry Executive Nominated to Lead Consumer Watchdog Agency
Nancy B. Beck, who once directed science policy at the American Chemistry Council, was nominated to lead the Consumer Product…
Chemical Industry Executive Nominated to Lead Consumer Watchdog Agency
Nancy B. Beck, who once directed science policy at the American Chemistry Council, was nominated to lead the Consumer Product…
Monthly Injectable Antiretroviral Therapy — Version 1.0 of a New Treatment Approach
Combination antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection is one of the most important advances…
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
Combination antiretroviral therapy can significantly prolong the life expectancy of people living with human immunodeficiency virus (HIV), but HIV infection…
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Combination antiretroviral therapy for human immunodeficiency virus type 1 (HIV-1) infection provides durable viral suppression, which is associated with improved…
Mapping the travel patterns of people with malaria in Bangladesh
Spread of malaria and antimalarial resistance through human movement present major threats to current goals to eliminate the disease. Bordering…